Categories AlphaGraphs, Earnings, Health Care

AbbVie (ABBV) Earnings: 4Q20 Key Numbers

AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today.

Worldwide net revenues rose 59.2% year-over-year to $13.8 billion on a reported basis. On an operational basis, sales rose 6.8%.

Net earnings attributable to AbbVie were $36 million, or $0.01 per share, compared to $2.8 billion, or $1.88 per share, last year. The GAAP results included a non-cash charge for Skyrizi contingent consideration revaluation based on higher estimated future sales. Adjusted EPS totaled $2.92.

Both revenue and earnings surpassed market projections.

For the full year of 2021, GAAP EPS is expected to be $6.69-6.89 and adjusted EPS is expected to be $12.32-12.52.

Prior performance

Abbvie Q3 2020 earnings

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

What awaits MongoDB (MDB) after the much-awaited turnaround?

MongoDB, Inc. (NASDAQ: MDB), the tech firm that pioneered a new method for creating databases, enables developers to work with high volumes of varied data effortlessly. The company this week

Earnings: A snapshot of GameStop’s Q3 2022 financial performance

GameStop Corp. (NYSE: GME) reported a narrower net loss for the third quarter of 2022 despite the gaming company’s sales decreasing year-over-year. The company reported a net loss of $94.7 million

Here’s why Signet Jewellers (SIG) is confident about its long-term growth opportunity

Shares of Signet Jewelers Limited (NYSE: SIG) were up 5% on Wednesday. The stock has gained 32% over the past three months. A day ago, the company delivered better-than-expected earnings

Add Comment
Viewing Highlight